SE431452B - Forfarande for framstellning av pyrazinkarboxamider - Google Patents

Forfarande for framstellning av pyrazinkarboxamider

Info

Publication number
SE431452B
SE431452B SE7613289A SE7613289A SE431452B SE 431452 B SE431452 B SE 431452B SE 7613289 A SE7613289 A SE 7613289A SE 7613289 A SE7613289 A SE 7613289A SE 431452 B SE431452 B SE 431452B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
carboxamides
pyrazine
pyrazine carboxamides
Prior art date
Application number
SE7613289A
Other languages
English (en)
Other versions
SE7613289L (sv
Inventor
Jr E J Cragoe
O W Woltersdorf
C N Habecker
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7613289L publication Critical patent/SE7613289L/sv
Publication of SE431452B publication Critical patent/SE431452B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7613289A 1975-12-15 1976-11-26 Forfarande for framstellning av pyrazinkarboxamider SE431452B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64080375A 1975-12-15 1975-12-15

Publications (2)

Publication Number Publication Date
SE7613289L SE7613289L (sv) 1977-06-16
SE431452B true SE431452B (sv) 1984-02-06

Family

ID=24569755

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613289A SE431452B (sv) 1975-12-15 1976-11-26 Forfarande for framstellning av pyrazinkarboxamider

Country Status (14)

Country Link
US (1) US4085211A (sv)
JP (1) JPS52106877A (sv)
AU (1) AU511429B2 (sv)
BE (1) BE849379A (sv)
CH (1) CH630369A5 (sv)
DE (1) DE2656374A1 (sv)
DK (1) DK531476A (sv)
ES (2) ES454160A1 (sv)
FR (1) FR2335226A1 (sv)
GB (1) GB1527297A (sv)
HU (1) HU175504B (sv)
NL (1) NL7613276A (sv)
SE (1) SE431452B (sv)
ZA (1) ZA767431B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208413A (en) * 1977-03-04 1980-06-17 Merck & Co., Inc. N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
US4163781A (en) * 1978-04-17 1979-08-07 Merck & Co., Inc. 3-Amino-N-[(phosphonoamino)iminomethyl]-6-halopyrazinecarboxamide compounds, compositions and methods of use
EP0009054A1 (en) * 1978-09-19 1980-04-02 Merck & Co. Inc. N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same
US4272537A (en) * 1980-07-02 1981-06-09 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides
US4277602A (en) * 1980-07-02 1981-07-07 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(3,4-dihydro-6-substituted-1,3,5-truazin-2-yl)2-pyrazinecarboxamides
FI820266L (fi) * 1981-02-02 1982-08-03 Ici Plc Alkanolaminderivater
US4594349A (en) * 1982-01-04 1986-06-10 Beyer Jr Karl H Hyperuretic agents
JPS62291361A (ja) * 1986-06-09 1987-12-18 株式会社ブリヂストン 床支持装置
JPS6342741U (sv) * 1986-09-04 1988-03-22
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8812342D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Bicyclic compounds
GB8812343D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Amino compounds
JPH02101937U (sv) * 1989-01-31 1990-08-14
AUPP646498A0 (en) * 1998-10-12 1998-11-05 Australian National University, The A method of modulating ion channel functional activity
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
WO2006023617A2 (en) * 2004-08-18 2006-03-02 Johnson Michael R Cyclic amide & ester pyrazinoylguanidine sodium channel blockers
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
GB0526244D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
AR069637A1 (es) 2007-12-10 2010-02-10 Novartis Ag Derivados de pirazinas
DE102008053024B4 (de) 2008-10-24 2015-04-30 RUHR-UNIVERSITäT BOCHUM Verwendung von Amilorid-Derivaten zur Bekämpfung von Insekten und Milben
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
ES2619954T3 (es) 2012-12-17 2017-06-27 Parion Sciences, Inc. Derivados de cloropiracinocarboxamida útiles para el tratamiento de enfermedades favorecidas por una hidratación mucosa insuficiente
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
WO2016043230A1 (ja) * 2014-09-18 2016-03-24 日産化学工業株式会社 液晶配向剤、液晶配向膜、及び液晶表示素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299931A (sv) * 1962-10-30
NL299929A (sv) * 1962-10-30

Also Published As

Publication number Publication date
ES454160A1 (es) 1978-03-01
DK531476A (da) 1977-06-16
BE849379A (fr) 1977-06-14
ES465742A1 (es) 1978-10-01
FR2335226A1 (fr) 1977-07-15
GB1527297A (en) 1978-10-04
DE2656374C2 (sv) 1989-08-10
CH630369A5 (de) 1982-06-15
AU2018176A (en) 1978-06-08
NL7613276A (nl) 1977-06-17
US4085211A (en) 1978-04-18
FR2335226B1 (sv) 1979-03-09
ZA767431B (en) 1978-07-26
HU175504B (hu) 1980-08-28
JPS6238350B2 (sv) 1987-08-17
AU511429B2 (en) 1980-08-21
SE7613289L (sv) 1977-06-16
DE2656374A1 (de) 1977-06-16
JPS52106877A (en) 1977-09-07

Similar Documents

Publication Publication Date Title
SE431452B (sv) Forfarande for framstellning av pyrazinkarboxamider
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
SE433937B (sv) Forfarande for framstellning av penicillinestrar
SE426065B (sv) Forfarande for framstellning av nikotinsyraamid
SE7611280L (sv) Forfarande for framstellning av 3-hydroxi-3-cefemestersulfoxider
SE7609281L (sv) Forfarande for framstellning av finkornig fast cyanurklorid
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE435716B (sv) Forfarande for framstellning av nya penicilliner
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE7605427L (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7613289-3

Effective date: 19900706

Format of ref document f/p: F